VistaGen Therapeutics Inc Cash Flow Reinvestment Rate
Latest as of September 2020:
0.20x
VistaGen Therapeutics Inc cash flow reinvestment rate. VistaGen Therapeutics Inc (VTGN) has a Cash Flow Reinvestment Rate of 0.20x as of September 2020, reinvesting $197.60K (capex $98.80K plus investments $-98.80K) from operating cash flow of $1.00 Million. Explore how well can VistaGen Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.20x
(Capex + Investments) / Operating CF
Total Reinvested
$197.60K
Capex + Investments
Operating Cash Flow
$1.00 Million
USD
Capital Expenditures
$98.80K
USD
VistaGen Therapeutics Inc Cash Flow Reinvestment Rate by Year (None–None)
VistaGen Therapeutics Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for VistaGen Therapeutics Inc. For the full cash flow conversion analysis, see VTGN cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow